Version 1
: Received: 31 May 2020 / Approved: 31 May 2020 / Online: 31 May 2020 (20:43:13 CEST)
How to cite:
Reddy, K. Bentonite Exposure in Western Pacific Amyotrophic Lateral Sclerosis/ Parkinsonism Dementia Complex and Neurodegenerative Diseases. Preprints2020, 2020050507. https://doi.org/10.20944/preprints202005.0507.v1.
Reddy, K. Bentonite Exposure in Western Pacific Amyotrophic Lateral Sclerosis/ Parkinsonism Dementia Complex and Neurodegenerative Diseases. Preprints 2020, 2020050507. https://doi.org/10.20944/preprints202005.0507.v1.
Cite as:
Reddy, K. Bentonite Exposure in Western Pacific Amyotrophic Lateral Sclerosis/ Parkinsonism Dementia Complex and Neurodegenerative Diseases. Preprints2020, 2020050507. https://doi.org/10.20944/preprints202005.0507.v1.
Reddy, K. Bentonite Exposure in Western Pacific Amyotrophic Lateral Sclerosis/ Parkinsonism Dementia Complex and Neurodegenerative Diseases. Preprints 2020, 2020050507. https://doi.org/10.20944/preprints202005.0507.v1.
Abstract
Neurodegenerative diseases of protein misfolding affect humans and animals. In humans, these diseases include Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Western Pacific amyotrophic lateral sclerosis and Parkinsonism-dementia complex (ALS/PDC). Mineral exposure may be important in the pathogenesis of protein misfolding cascades. The possible association of bentonite, montmorillonite, and mineral risk factors with Alzheimer’s disease, Parkinson’s disease, ALS, and Western Pacific ALS/PDC is analyzed and discussed.
Keywords
neurodegeneration; protein misfolding; Western Pacific; Guam; montmorillonite; bentonite; clay; mineral; ALS; Parkinson’s disease
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.